SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

SCHEDULE 13G

UNDER THE SECURITIES EXCHANGE ACT OF 1934

(Amendment No. 1)

Picard Medical, Inc.

(Name of Issuer)

Common Stock, $0.0001 par value per share

(Title of Class of Securities)

740459102

(CUSIP Number)

06/03/2025

(Date of Event Which Requires Filing of this Statement)

Check the appropriate box to designate the rule pursuant to which this Schedule is filed:

Rule 13d-1(b)

Rule 13d-1(c)

Rule 13d-1(d)

SCHEDULE 13G

CUSIP Number(s):

740459102

Names of Reporting Persons

Sindex SSI Lending, LLC

Check the appropriate box if a member of a Group (see instructions)

(a)

(b)

Sec Use Only

Citizenship or Place of Organization

DELAWARE

Number of Shares Beneficially Owned by Each Reporting Person With:

5	Sole Voting Power 0.00
6	Shared Voting Power 0.00
7	Sole Dispositive Power 0.00
8	Shared Dispositive Power 0.00

Aggregate Amount Beneficially Owned by Each Reporting Person

0.00

Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)

Checkbox not checked

Percent of class represented by amount in row (9)

0.00 %

Type of Reporting Person (See Instructions)

SCHEDULE 13G

CUSIP Number(s):

740459102

Names of Reporting Persons

Versa Capital Fund III, L.P.

Check the appropriate box if a member of a Group (see instructions)

(a)

(b)

Sec Use Only

Citizenship or Place of Organization

DELAWARE

Number of Shares Beneficially Owned by Each Reporting Person With:

5	Sole Voting Power 0.00
6	Shared Voting Power 0.00
7	Sole Dispositive Power 0.00
8	Shared Dispositive Power 0.00

Aggregate Amount Beneficially Owned by Each Reporting Person

0.00

Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)

Checkbox not checked

Percent of class represented by amount in row (9)

0 %

Type of Reporting Person (See Instructions)

SCHEDULE 13G

CUSIP Number(s):

740459102

Names of Reporting Persons

Versa FGP-III, L.P.

Check the appropriate box if a member of a Group (see instructions)

(a)

(b)

Sec Use Only

Citizenship or Place of Organization

DELAWARE

Number of Shares Beneficially Owned by Each Reporting Person With:

5	Sole Voting Power 0.00
6	Shared Voting Power 0.00
7	Sole Dispositive Power 0.00
8	Shared Dispositive Power 0.00

Aggregate Amount Beneficially Owned by Each Reporting Person

0.00

Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)

Checkbox not checked

Percent of class represented by amount in row (9)

0 %

Type of Reporting Person (See Instructions)

SCHEDULE 13G

CUSIP Number(s):

740459102

Names of Reporting Persons

Versa UGP-III, LLC

Check the appropriate box if a member of a Group (see instructions)

(a)

(b)

Sec Use Only

Citizenship or Place of Organization

DELAWARE

Number of Shares Beneficially Owned by Each Reporting Person With:

5	Sole Voting Power 0.00
6	Shared Voting Power 0.00
7	Sole Dispositive Power 0.00
8	Shared Dispositive Power 0.00

Aggregate Amount Beneficially Owned by Each Reporting Person

0.00

Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)

Checkbox not checked

Percent of class represented by amount in row (9)

0 %

Type of Reporting Person (See Instructions)

SCHEDULE 13G

CUSIP Number(s):

740459102

Names of Reporting Persons

Versa Capital Group, LLC

Check the appropriate box if a member of a Group (see instructions)

(a)

(b)

Sec Use Only

Citizenship or Place of Organization

DELAWARE

Number of Shares Beneficially Owned by Each Reporting Person With:

5	Sole Voting Power 0.00
6	Shared Voting Power 0.00
7	Sole Dispositive Power 0.00
8	Shared Dispositive Power 0.00

Aggregate Amount Beneficially Owned by Each Reporting Person

0.00

Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)

Checkbox not checked

Percent of class represented by amount in row (9)

0 %

Type of Reporting Person (See Instructions)

SCHEDULE 13G

CUSIP Number(s):

740459102

Names of Reporting Persons

Gregory L. Segall

Check the appropriate box if a member of a Group (see instructions)

(a)

(b)

Sec Use Only

Citizenship or Place of Organization

DELAWARE

Number of Shares Beneficially Owned by Each Reporting Person With:

5	Sole Voting Power 0.00
6	Shared Voting Power 0.00
7	Sole Dispositive Power 0.00
8	Shared Dispositive Power 0.00

Aggregate Amount Beneficially Owned by Each Reporting Person

0.00

Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)

Checkbox not checked

Percent of class represented by amount in row (9)

0 %

Type of Reporting Person (See Instructions)

SCHEDULE 13G

Item 1.

(a)

Name of issuer:

Picard Medical, Inc.

(b)

Address of issuer's principal executive offices:

1992 E. Silverlake Rd. Tucson, AZ, 85713

Item 2.

(a)

Name of person filing:

(1) Sindex SSI Lending, LLC, a Delaware limited liability company ("Sindex") (2) Versa Capital Fund III, L.P., a Delaware limited partnership ("CF III") (3) Versa FGP-III, L.P., a Delaware limited partnership ("FGP-III") (4) Versa UGP-III, LLC, a Delaware limited liability company ("UGP-III") (5) Versa Capital Group, LLC, a Delaware limited liability company ("Versa") (6) Gregory L. Segall, an individual ("Mr. Segall" and, together with Sindex, CF III, FGP III, UGP III, and Versa, the "Reporting Persons")

(b)

Address or principal business office or, if none, residence:

c/o Versa Capital Management, LLC 130 N. 18th Street Suite 315 Philadelphia, PA 19103

(c)

Citizenship:

Mr. Segall is a citizen of the United States. The other Reporting Persons were formed under the laws of the State of Delaware.

(d)

Title of class of securities:

Common Stock, $0.0001 par value per share

(e)

CUSIP No.:

740459102

Item 3.

If this statement is filed pursuant to §§ 240.13d-1(b) or 240.13d-2(b) or (c), check whether the person filing is a:

(a)

Broker or dealer registered under section 15 of the Act (15 U.S.C. 78o);

(b)

Bank as defined in section 3(a)(6) of the Act (15 U.S.C. 78c);

(c)

Insurance company as defined in section 3(a)(19) of the Act (15 U.S.C. 78c);

(d)

Investment company registered under section 8 of the Investment Company Act of 1940 (15 U.S.C. 80a-8);

(e)

An investment adviser in accordance with § 240.13d-1(b)(1)(ii)(E);

(f)

An employee benefit plan or endowment fund in accordance with § 240.13d-1(b)(1)(ii)(F);

(g)

A parent holding company or control person in accordance with § 240.13d-1(b)(1)(ii)(G);

(h)

A savings associations as defined in Section 3(b) of the Federal Deposit Insurance Act (12 U.S.C. 1813);

(i)

A church plan that is excluded from the definition of an investment company under section 3(c)(14) of the Investment Company Act of 1940 (15 U.S.C. 80a-3);

(j)

A non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J). If filing as a non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J),
please specify the type of institution:

(k)

Group, in accordance with Rule 240.13d-1(b)(1)(ii)(K).

Item 4.

Ownership

(a)

Amount beneficially owned:

Sindex SSI Lending, LLC: 0 Versa Capital Fund III, L.P.: 0 Versa FGP-III, L.P.: 0 Versa UGP-III, LLC: 0 Versa Capital Group, LLC: 0 Gregory L. Segall: 0

(b)

Percent of class:

Sindex SSI Lending, LLC: 0.00% Versa Capital Fund III, L.P.: 0.00% Versa FGP-III, L.P.: 0.00% Versa UGP-III, LLC: 0.00% Versa Capital Group, LLC: 0.00% Gregory L. Segall: 0.00%

(c)

Number of shares as to which the person has:

(i) Sole power to vote or to direct the vote:

Sindex SSI Lending, LLC: 0 Versa Capital Fund III, L.P.: 0 Versa FGP-III, L.P.: 0 Versa UGP-III, LLC: 0 Versa Capital Group, LLC: 0 Gregory L. Segall: 0

(ii) Shared power to vote or to direct the vote:

Sindex SSI Lending, LLC: 0 Versa Capital Fund III, L.P.: 0 Versa FGP-III, L.P.: 0 Versa UGP-III, LLC: 0 Versa Capital Group, LLC: 0 Gregory L. Segall: 0

(iii) Sole power to dispose or to direct the disposition of:

Sindex SSI Lending, LLC: 0 Versa Capital Fund III, L.P.: 0 Versa FGP-III, L.P.: 0 Versa UGP-III, LLC: 0 Versa Capital Group, LLC: 0 Gregory L. Segall: 0

(iv) Shared power to dispose or to direct the disposition of:

Sindex SSI Lending, LLC: 0 Versa Capital Fund III, L.P.: 0 Versa FGP-III, L.P.: 0 Versa UGP-III, LLC: 0 Versa Capital Group, LLC: 0 Gregory L. Segall: 0

Item 5.

Ownership of 5 Percent or Less of a Class.

Ownership of 5 percent or less of a class

Item 6.

Ownership of more than 5 Percent on Behalf of Another Person.

Not Applicable

Item 7.

Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on by the Parent Holding Company or Control Person.

Not Applicable

Item 8.

Identification and Classification of Members of the Group.

Not Applicable

Item 9.

Notice of Dissolution of Group.

Not Applicable

Item 10.

Certifications:

By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under § 240.14a-11.

SIGNATURE

After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

Sindex SSI Lending, LLC

Signature:	/s/ Randall Schultz
Name/Title:	Randall Schultz, as Attorney-in-Fact for: Sindex SSI Lending, LLC (1)
Date:	06/05/2026

Versa Capital Fund III, L.P.

Signature:	/s/ Randall Schultz
Name/Title:	Randall Schultz, as Attorney-in-Fact for: Versa Capital Fund III, L.P. (1)
Date:	06/05/2026

Versa FGP-III, L.P.

Signature:	/s/ Randall Schultz
Name/Title:	Randall Schultz, as Attorney-in-Fact for: Versa FGP-III, L.P. (1)
Date:	06/05/2026

Versa UGP-III, LLC

Signature:	/s/ Randall Schultz
Name/Title:	Randall Schultz, as Attorney-in-Fact for: Versa UGP-III, LLC (1)
Date:	06/05/2026

Versa Capital Group, LLC

Signature:	/s/ Randall Schultz
Name/Title:	Randall Schultz, as Attorney-in-Fact for: Versa Capital Group, LLC (1)
Date:	06/05/2026

Gregory L. Segall

Signature:	/s/ Randall Schultz
Name/Title:	Randall Schultz, as Attorney-in-Fact for: Gregory L. Segall (1)
Date:	06/05/2026

Comments accompanying signature: (1) A Power of Attorney authorizing Randall Schultz to act on behalf of this entity or individual was filed as Exhibit 2 to the statement on Schedule 13G filed on November 13, 2025.

Amendment: SEC Form SCHEDULE 13G/A filed by Picard Medical Inc.